UBS Cite Efficient Capital Allocation and Rising Profits in Viatris Inc. (VTRS) Upgrade

Viatris Inc. (NASDAQ:VTRS) is among the 7 Cheap Pharmaceutical Stocks to Buy According to Hedge Funds. UBS Cite Efficient Capital Allocation and Rising Profits in Viatris Inc. (VTRS) Upgrade The third stock on our list of cheap pharmaceutical stocks is Viatris Inc. (NASDAQ:VTRS). TheFly reported on February 9 that UBS upgraded VTRS to Buy from Neutral and raised the price target to $18 from $11. The company's stronger growth prospects are reflected in the upgrade. VTRS' new product pipeline and continuo ...